Crossmark Global Holdings
RPRX icon

Crossmark Global Holdings’s Royalty Pharma RPRX Stock Holding History

Crossmark Global Holdings’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$695K Buy
11,902
+2,139
+22% +$126K 0.01% 733
2026
Q2 		$547K Hold
9,763
– – 0.01% 838
2026
Q1 		$468K Hold
9,763
– – 0.01% 850
2025
Q4 		$377K Buy
+9,763
New +$372K 0.01% 941

Other funds holding RPRX

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Eastern Bank
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Hosking Partners
Hosking Partners London, United Kingdom $2.81B AUM 67.07% 1-Year Est. Return
Kepler Cheuvreux
Kepler Cheuvreux Nyon $1.65B AUM 36.86% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Kirr Marbach & Co
Kirr Marbach & Co Columbus, Indiana $530M AUM 14.37% 1-Year Est. Return
Triasima Portfolio Management
Triasima Portfolio Management Montreal, Quebec, Canada $758M AUM 48.16% 1-Year Est. Return
Sumitomo Mitsui DS Asset Management
Sumitomo Mitsui DS Asset Management Tokyo, Japan $14.8B AUM 30.39% 1-Year Est. Return

Crossmark Global Holdings's RPRX Position: Q3 2026 in Review

Crossmark Global Holdings increased its Royalty Pharma (RPRX) stake by 22% in Q3 2026, buying an estimated $126K and bringing the position to 11,902 shares worth $695K. The position accounts for 0.01% of the portfolio, ranked #733.

Crossmark Global Holdings first reported a position in RPRX in Q4 2025 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Crossmark Global Holdings held 11,902 shares of Royalty Pharma worth $695K as of Q3 2026.
  • Crossmark Global Holdings bought 2,139 Royalty Pharma shares in Q3 2026, an estimated $126K.
  • Royalty Pharma made up 0.01% of Crossmark Global Holdings's portfolio in Q3 2026, its #733 holding.
  • Crossmark Global Holdings first reported a position in Royalty Pharma in Q4 2025 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Crossmark Global Holdings's 13F filing for Q3 2026, filed 21 Oct 2026.